HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies (Hepatica)
Sponsor: Hampshire Hospitals NHS Foundation Trust
Listed as NCT03213314, this NA trial focuses on Colorectal Cancer Metastatic and Liver Cancer and remains completed. Sponsored by Hampshire Hospitals NHS Foundation Trust, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2019 — Nov 2020 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Oct 2017 [monthly]
Not Yet Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hampshire Hospitals NHS Foundation Trust
- Perspectum
- University of Edinburgh
For direct contact, visit the study record on ClinicalTrials.gov .